مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

211
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

152
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMPARISON DIFFERENT ORAL GLUCOSE LOWERING DRUGS EFFECTS ON FASTING PATIENTS WITH TYPE II DIABETES

Pages

  59-66

Abstract

 Introduction: TYPE II DIABETES is the most common metabolic diseases in developed and developing countries with no effective treatment options. This study purpose was to compare different regimens of oral anti-diabetic therapy effects on the type II diabetic patients while fasting during Ramadan.Methods: In the double-blind clinical trial 90 patients with TYPE II DIABETES were divided randomly into three groups: 30 patients continued the previous dose of SULFONYLUREA (Group 1), 30 participants received a dose which was 25% lower than the previous SULFONYLUREA dose (group 2), and in the last 30 patients, REPAGLINIDE was replaced SULFONYLUREA (Group 3). Glucose, glycosylated hemoglobin (HbA1C), fructosamine, total cholesterol, low-density lipoprotein (LDL), high density lipoprotein (HDL), and triglycerides levels were measured in all participants before and after Ramadan. The weight and BMI were also controlled.Results: In all intervention groups a significant decreasing was seen in the body weight, BMI, fructose amine, total cholesterol, and LDL; and also, a significant increasing was seen in HDL. The HYPOGLYCEMIA incidence was significantly lower in Group 3 than Group 1. The results in fructosamine reduction and HDL cholesterol increasing were significantly better in Group 3 compared to Group 2 (P<0.05). Significant changes were not seen in total cholesterol, LDL, triglyceride, FBS, and HbA1C levels among the three treatment groups during Ramadan.Conclusion: The REPAGLINIDE consumption in comparing with SULFONYLUREA in patients with diabetes during Ramadan can cause fewer HYPOGLYCEMIA, and better glycemic, and lipid control.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    ZAKERKISH, MEHRNOOSH, SHAHBAZIAN, HAJIYEH BIBI, KARANDISH, MAJID, RASHIDI, HOMEIRA, & PAYAMI, SEYED PEYMAN. (2018). COMPARISON DIFFERENT ORAL GLUCOSE LOWERING DRUGS EFFECTS ON FASTING PATIENTS WITH TYPE II DIABETES. INTERNATIONAL JOURNAL OF BIOMEDICINE AND PUBLIC HEALTH, 1(2), 59-66. SID. https://sid.ir/paper/350862/en

    Vancouver: Copy

    ZAKERKISH MEHRNOOSH, SHAHBAZIAN HAJIYEH BIBI, KARANDISH MAJID, RASHIDI HOMEIRA, PAYAMI SEYED PEYMAN. COMPARISON DIFFERENT ORAL GLUCOSE LOWERING DRUGS EFFECTS ON FASTING PATIENTS WITH TYPE II DIABETES. INTERNATIONAL JOURNAL OF BIOMEDICINE AND PUBLIC HEALTH[Internet]. 2018;1(2):59-66. Available from: https://sid.ir/paper/350862/en

    IEEE: Copy

    MEHRNOOSH ZAKERKISH, HAJIYEH BIBI SHAHBAZIAN, MAJID KARANDISH, HOMEIRA RASHIDI, and SEYED PEYMAN PAYAMI, “COMPARISON DIFFERENT ORAL GLUCOSE LOWERING DRUGS EFFECTS ON FASTING PATIENTS WITH TYPE II DIABETES,” INTERNATIONAL JOURNAL OF BIOMEDICINE AND PUBLIC HEALTH, vol. 1, no. 2, pp. 59–66, 2018, [Online]. Available: https://sid.ir/paper/350862/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button